BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.85% |
| 2 | Financials | 5.5% |
| 3 | Healthcare | 5.05% |
| 4 | Consumer Discretionary | 4.67% |
| 5 | Industrials | 3.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COHR
2226
DELISTED
Coherent Inc
COHR
| $606K | ﹤0.01% |
3,643
-1,642
| -31% | -$254K |
|
2227
Bloomin' Brands
BLMN
$902M
| $605K | ﹤0.01% |
27,400
+11,585
| +73% | +$246K |
|
2228
Emergent Biosolutions
EBS
$238M
| $604K | ﹤0.01% |
11,204
+2,952
| +36% | +$160K |
|
|
MINI
2229
DELISTED
Mobile Mini Inc
MINI
| $604K | ﹤0.01% |
15,928
+7,796
| +96% | +$294K |
|
|
MLNX
2230
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $604K | ﹤0.01% |
5,152
-3,439
| -40% | -$391K |
|
2231
Bank OZK
OZK
$5.73B
| $602K | ﹤0.01% |
19,733
-9,161
| -32% | -$269K |
|
2232
PUT
State Street
STT
$52.4B
| $601K | ﹤0.01% |
76
| – | – |
|
|
WW
2233
DELISTED
WW International
WW
| $599K | ﹤0.01% |
+15,680
| New | +$595K |
|
|
ESGR
2234
DELISTED
Enstar Group
ESGR
| $597K | ﹤0.01% |
2,884
+474
| +20% | +$94.8K |
|
|
MGLN
2235
DELISTED
Magellan Health Services, Inc.
MGLN
| $596K | ﹤0.01% |
7,620
+3,550
| +87% | +$250K |
|
2236
Edgewell Personal Care
EPC
$1.31B
| $596K | ﹤0.01% |
19,250
+8,953
| +87% | +$289K |
|
2237
Dycom Industries
DY
$12.5B
| $595K | ﹤0.01% |
12,610
+6,716
| +114% | +$327K |
|
2238
Rambus
RMBS
$10.8B
| $593K | ﹤0.01% |
43,063
+23,340
| +118% | +$313K |
|
2239
S&T Bancorp
STBA
$1.81B
| $593K | ﹤0.01% |
14,720
+8,572
| +139% | +$325K |
|
|
CADE
2240
DELISTED
Cadence Bank
CADE
| $592K | ﹤0.01% |
18,846
-618
| -3% | -$19.1K |
|
|
VRE
2241
DELISTED
Veris Residential
VRE
| $592K | ﹤0.01% |
25,591
-5,248
| -17% | -$114K |
|
2242
Crane NXT
CXT
$2.97B
| $592K | ﹤0.01% |
19,721
-3,222
| -14% | -$91.7K |
|
2243
NETSCOUT
NTCT
$2.88B
| $592K | ﹤0.01% |
24,582
+10,171
| +71% | +$240K |
|
2244
AAR Corp
AIR
$5.9B
| $592K | ﹤0.01% |
13,116
+7,127
| +119% | +$309K |
|
2245
Provident Financial Services
PFS
$3.22B
| $589K | ﹤0.01% |
23,883
+12,715
| +114% | +$314K |
|
|
TRTN
2246
DELISTED
Triton International Limited
TRTN
| $588K | ﹤0.01% |
14,628
+4,614
| +46% | +$171K |
|
2247
Deutsche Bank
DB
$72.5B
| $587K | ﹤0.01% |
75,394
-26,068
| -26% | -$196K |
|
2248
PUT
iShares US Real Estate ETF
IYR
$4.59B
| $586K | ﹤0.01% |
63
| – | – |
|
2249
Open Text
OTEX
$5.92B
| $586K | ﹤0.01% |
13,301
-28,233
| -68% | -$1.19M |
|
2250
Myriad Genetics
MYGN
$299M
| $585K | ﹤0.01% |
21,490
+6,772
| +46% | +$186K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, down from 8.4% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.